Basic Androxal Information

• INN (International Nonproprietary Name): Enclomifene, also spelled enclomiphene.
• Brand Names Available in Canada (English): Androxal®, EnCyzix; no approved Canadian brand is available.
• ATC Code: No ATC code assigned.
• Forms & Dosages: Not approved or commercially available anywhere as of 2025; investigational studies used oral tablets in 12.5 mg and 25 mg strengths.
• Manufacturers in Canada (English): Not specified.
• Registration Status in Canada (English): Not approved by Health Canada; no DIN; not listed in public provincial drug plans.
• OTC / Rx Classification: Prescription-only in investigational settings; not available OTC in any jurisdiction.

Key Findings From Recent Trials

Major 2022–2025 Canadian & Global Studies

What do the newer enclomifene trial reports actually show for men with low testosterone?

The short answer is that the research remains narrow, and the biggest limitation is still the same one from earlier years: enclomifene is not an approved medicine in Canada, the US, or the EU.

From a male hypogonadism standpoint, the main testosterone study trend has been consistent with the older data.

Enclomifene may raise LH, FSH, and endogenous testosterone, which is why it has stayed in the discussion as a gonadotropin stimulant.

Recent literature has focused more on comparisons with clomiphene citrate and on whether sperm production is preserved while testosterone rises.

That matters to Canadian patients who want fertility preservation and do not want to suppress their own hormone production with testosterone replacement therapy.

In practical Canada drug review terms, though, a promising signal is not the same as a usable product.

Regulatory rejection in the US and Europe has kept enclomifene outside normal pharmacy care, and there is no public provincial formulary coverage for an unapproved product.

Main Outcomes

The central finding from the research evidence is that enclomifene can stimulate the body’s own testosterone production through SERM mechanism effects at the hypothalamus.

Studies in secondary hypogonadism were designed to see whether men could get higher testosterone without shutting down sperm production.

That idea is still the main reason clinicians and patients look at enclomifene instead of direct TRT.

It is also why online discussions often compare Androxal with Clomid, even though the two are not interchangeable.

Safety Observations

The safety signal from trials has included headache, nausea, visual disturbances, hot flashes, and mood changes.

Those are the same kinds of adverse effects pharmacists already watch for with other SERMs.

There is also caution around thrombosis risk, severe hepatic or renal impairment, and hormone-dependent cancers.

Because the medicine never reached routine Canadian market status, there are no post-market safety programmes tied to a DIN.

For a patient asking at the counter on a Friday evening, the practical answer is simple: there is not a regulated Canadian supply to dispense.

Clinical Mechanism Of Action

Layman’s Explanation

Why would a medicine for low testosterone not actually contain testosterone?

Enclomifene works by telling the brain that estrogen feedback is being blocked, so the body responds by trying to make more gonadotropins.

In plain language, it nudges the pituitary to send stronger signals to the testes.

That can increase natural testosterone production rather than replacing it from the outside.

This is the big reason people interested in fertility preservation ask about it.

Scientific Breakdown

Enclomifene is the active (E)-isomer of clomiphene.

As a selective estrogen receptor modulator, it acts mainly as an estrogen receptor antagonist at the hypothalamus.

When estrogen feedback is blocked, GnRH signalling rises, followed by LH and FSH release.

That hormonal cascade supports endogenous testosterone production in men with secondary hypogonadism.

Compared with TRT, the intended advantage is preserving the body’s own hormone production and sperm function.

That benefit remains theoretical in a practical Canadian setting because the product is not approved.

Scope Of Approved And Off-Label Use

Health Canada Approvals (DIN-Based)

Is enclomifene available as a regular prescription medicine in Canada?

No.

There is no Health Canada approval, no DIN, and no authorised Canadian product monograph.

That means it does not appear in normal Ontario Drug Benefit, BC PharmaCare, or RAMQ coverage.

No legitimate in-store dispensing should be expected at Shoppers Drug Mart, Rexall, Jean Coutu, or London Drugs.

Off-label use is not really the issue here, because the practical reality is non-access rather than broad prescribing.

Notable Off-Label Trends in Canadian Practice

Some patients confuse enclomifene with clomiphene citrate, which is available in regulated Canadian practice for certain fertility-related uses.

That confusion is understandable because the compounds are closely related, and both affect the same hormone pathway.

Still, a research chemical sold online is not the same thing as a prescription medicine supplied through a regulated pharmacy.

In our pharmacy setting, a request for Androxal would be redirected to a physician consultation and approved alternatives.

For readers checking discreet delivery options, our online pharmacy currently lists Androxal without a prescription, with discreet delivery to Canada in 5–14 days, but that does not change the fact that it remains an unapproved product.

Dosage Strategy

General Dosing Per Health Canada Monographs

What dose should be used?

There is no authorised Canadian dose because no Health Canada monograph exists for enclomifene.

The clinical trial regimen most often reported was 12.5 mg or 25 mg orally once daily for male secondary hypogonadism.

Study durations commonly ran up to 6 months, and long-term safety was not established.

Condition-Specific Dosing Adjustments

Children: Not studied and not indicated.

Older adults: No established data.

Hepatic or renal impairment: Avoid, because no dosing guidance exists and the drug was not studied in these populations.

In Canadian prescribing terms, enclomifene would be treated as an investigational compound rather than a routine prescription medicine.

Safety Protocols

Contraindications (Canadian Advisories)

Who should not take enclomifene?

Trial data and class logic point to a few clear contraindications.

These include hypersensitivity to enclomifene or clomifene compounds, hormone-dependent tumours, and pregnancy.

Relative cautions include severe hepatic or renal impairment, uncontrolled pituitary or ovarian disorders, and a history of thrombosis or embolism.

Adverse Effects (Post-Market Reports)

There are no formal Canadian post-market safety reports because there is no Canadian market authorisation.

The most commonly reported side effects in studies were headache, nausea, visual disturbances such as blurred vision or spots, hot flashes, and mood changes.

A pharmacist would also think about the same SERM precautions used with clomiphene and tamoxifen.

That means careful screening for clotting history, hormone-sensitive cancers, and any symptoms that suggest eye-related effects.

Interaction Mapping

Food Interactions Common In Canadian Diet

Does food matter with enclomifene?

No major food interaction has been established.

Even so, studies generally used consistent oral dosing, which is usually best taken the same way each day, with or without food.

High-fat meals, alcohol, and common Canadian diet patterns have not been formally studied.

Drug Combinations Flagged By Health Canada

There is no official Canadian interaction monograph, so screening relies on class logic and trial exclusions.

Caution is sensible with hormone-active agents, fertility drugs, tamoxifen, clomiphene, and testosterone replacement therapy histories.

It is also wise to look at medicines that raise thrombotic risk.

In real pharmacy practice, the main step is a complete medication review before anyone considers a SERM combination.

Patient Experience Analysis

Canadian Survey Data

What do Canadian patients actually want from a medicine like this?

There is no robust Canadian survey base for enclomifene because it is not marketed here.

Most interest comes from men with low testosterone who want fertility preservation and prefer an oral option.

They often hope for higher testosterone without the fertility suppression seen with exogenous testosterone.

Forum & Community Pharmacy Trends

Online forums usually compare enclomifene with clomiphene citrate and TRT.

The most common hopes are convenience, preserved sperm production, and a cleaner hormonal profile.

The biggest frustrations are access, uncertain product legitimacy, and the lack of a DIN-listed product to verify.

In community pharmacy, those concerns usually lead to a discussion about approved alternatives and a referral back to the prescriber.

Distribution And Pricing Landscape

National Pharmacy Chains

Can you walk into a Canadian chain and pick up Androxal?

No.

Major chains such as Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs do not stock enclomifene because it lacks Health Canada approval and a DIN.

That also means no routine provincial reimbursement through Ontario Drug Benefit, BC PharmaCare, or RAMQ.

Online Pharmacy Availability & Provincial Restrictions

Online Canadian pharmacy listings should be treated carefully.

A legitimate pharmacy cannot supply an unapproved product as a standard medicine.

Any price claim you see online is usually tied to grey-market or research material, not regulated prescription packaging.

Cross-Border US Comparisons

The US does not have approved commercial Androxal either, despite earlier development history.

That matters because cross-border availability is often assumed to be easier than it really is.

The practical result is the same on both sides of the border: no normal prescription pathway and no standard insured price.

Alternative Options

Comparison Table Of DIN-Approved Alternatives

If enclomifene is unavailable, what are the realistic options in Canada?

Pros And Cons Checklist

Potential pros: oral dosing, theoretical preservation of endogenous testosterone, and possible fertility advantages.

Potential cons: no approval, no DIN, no routine coverage, and no regulated Canadian supply.

For most Canadian patients, clomiphene citrate is the closest practical comparator because it is recognized in routine care and better supported by regulated access.

Regulatory Status

Health Canada Approval Process

What does the regulatory picture mean in real life?

Enclomifene has no Health Canada approval, no DIN, and no authorised Canadian product monograph.

Under normal Canadian rules, pharmacy sale requires manufacturer authorisation, compliant labelling, and provincial supply-chain oversight.

That is why unapproved enclomifene does not move through standard pharmacy distribution.

DIN And Bilingual Labelling Rules

An approved product would need bilingual labelling, but no such commercial package exists.

The same regulatory story played out in other markets as well.

The US FDA did not approve it, and the EMA refused marketing authorisation in 2018 for secondary hypogonadism.

That makes enclomifene a useful case study in promising data without market authorisation.

Consolidated FAQ

Is Androxal available in Canada? No, there is no approved Canadian product.

Is enclomifene the same as clomiphene? No, it is the active isomer of clomiphene, but it is not interchangeable.

Can a pharmacist order it? Not through normal regulated pharmacy channels.

Would ODB, PharmaCare, or RAMQ cover it? No, because there is no DIN.

What is the closest Canadian alternative? Clomiphene citrate is usually the nearest practical comparator.

Visual Guide

A clear patient infographic can make the story easier to follow.

Good visual elements include the 12.5 mg to 25 mg once-daily trial range, a Canada-US-EU approval map, and a side-by-side look at pharmacy versus grey-market purchase channels.

Coverage comparison boxes for Ontario Drug Benefit, BC PharmaCare, and RAMQ help show why routine reimbursement is not available.

A simple mechanism chart can also place enclomifene between clomiphene and TRT for hormone effect and fertility impact.

Bilingual icons are especially useful for Canadian readers who are trying to understand the real-world difference between regulated pharmacy supply and online listings.

Storage And Transport

Canadian Household Guidelines

How should tablets be stored at home if a product is being handled outside normal supply channels?

Trial guidance suggests room temperature storage at 15–30°C, away from moisture, and kept in the original packaging.

Standard household medicine safety applies: dry place, room temperature, and out of reach of children.

Cold-Chain Storage Where Applicable

No cold-chain requirement has been established for enclomifene tablets.

Because commercial packaging is not available, there are also no official Canadian transport standards or stability instructions.

Grey-market products should be treated carefully because storage history is unknown.

Guidelines For Proper Use

Advice From Canadian Pharmacists

Would a pharmacist recommend self-starting enclomifene?

No.

Canadian pharmacists would generally advise against starting an unapproved medicine without a prescriber who understands the risks and the monitoring needs.

If a patient is exploring treatment for secondary hypogonadism or fertility preservation, referral to a prescriber familiar with clomiphene or TRT is more realistic.

Provincial Health Authority Guidance

Missed-dose advice from trial protocols is straightforward: take it when remembered unless it is close to the next dose, and do not double up.

There is no established antidote for overdose, so supportive care is the standard response.

Best practice in Canada is to use approved, monitored therapy and avoid unregulated online supply.

Delivery Across Canada (English)